Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Supply Chain Blueprint
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Menu
New White Paper
- Read AAM Report on Drug Shortages
Learn More
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Sep 13, 2023
| Jewel Smith
Member Spotlight: Biocon Biologics
Press Release
Sep 6, 2023
| Monét Stanford
Generic and Biosimilar Drugs Generate $408 Billion in Savings For America’s Patients and Health-Care System in 2022
Report
Sep 6, 2023
| Monét Stanford
Report: 2023 U.S. Generic and Biosimilar Medicines Savings Report
Blog
Jul 17, 2023
| Craig Burton
Pharmacy Benefit Managers Are Blocking Patient Access to Biosimilar Insulin
Press Release
Jul 5, 2023
| Susan Reilly
AAM Requests Federal Injunction to Block Minnesota’s Unconstitutional Drug Price Law
Blog
Jun 28, 2023
| Monét Stanford
U.S. Patients Rely On Generic Medicines But Increases In Drug Shortages Reflect Challenges To Their Long-Term Sustainability
Report
Jun 22, 2023
| Erica Klinger
AAM White Paper on Shortages
Press Release
May 15, 2023
| Susan Reilly
AAM Statement on U.S. Supreme Court Decision to Decline Hearing GSK v. Teva
Blog
May 12, 2023
| Jewel Smith
Associate Members Spotlight: Antheia
Press Release
May 11, 2023
| Susan Reilly
4GRxANTED Campaign Generates Millions of Doses of Generic Medicine for Patients in Need
Blog
May 10, 2023
| Erica Klinger
Shamekka Shares Why We Should Never Take Moms #4GRxANTED
Video
Mar 29, 2023
| Erica Klinger
Join Us at GRx+Biosims 2023
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
GRx+Biosims 2022
Access! 2022
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Supply Chain Blueprint
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action